Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant Z DeFilipp, PP Bloom, M Torres Soto, MK Mansour, MRA Sater, ... New England Journal of Medicine 381 (21), 2043-2050, 2019 | 939 | 2019 |
International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai Acute GVHD International Consortium AC Harris, R Young, S Devine, WJ Hogan, F Ayuk, U Bunworasate, ... Biology of Blood and Marrow Transplantation 22 (1), 4-10, 2016 | 628 | 2016 |
Ipilimumab for patients with relapse after allogeneic transplantation MS Davids, HT Kim, P Bachireddy, C Costello, R Liguori, A Savell, ... New England Journal of Medicine 375 (2), 143-153, 2016 | 569 | 2016 |
Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results … P Armand, A Nagler, EA Weller, SM Devine, DE Avigan, YB Chen, ... Journal of clinical oncology 31 (33), 4199, 2013 | 553 | 2013 |
B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large … M Snuderl, OK Kolman, YB Chen, JJ Hsu, AM Ackerman, P Dal Cin, ... The American journal of surgical pathology 34 (3), 327-340, 2010 | 464 | 2010 |
Effect of inpatient palliative care on quality of life 2 weeks after hematopoietic stem cell transplantation: a randomized clinical trial A El-Jawahri, T LeBlanc, H VanDusen, L Traeger, JA Greer, WF Pirl, ... Jama 316 (20), 2094-2103, 2016 | 364 | 2016 |
Prostaglandin-modulated umbilical cord blood hematopoietic stem cell transplantation C Cutler, P Multani, D Robbins, HT Kim, T Le, J Hoggatt, LM Pelus, ... Blood, The Journal of the American Society of Hematology 122 (17), 3074-3081, 2013 | 350 | 2013 |
Primary effusion lymphoma YB Chen, A Rahemtullah, E Hochberg The Oncologist 12 (5), 569-576, 2007 | 328 | 2007 |
Prospective, randomized, double-blind, phase III clinical trial of anti–T-lymphocyte globulin to assess impact on chronic graft-versus-host disease–free survival in patients … RJ Soiffer, HT Kim, J McGuirk, ME Horwitz, L Johnston, MM Patnaik, ... Journal of Clinical Oncology 35 (36), 4003, 2017 | 282 | 2017 |
PD-1 blockade for relapsed lymphoma post–allogeneic hematopoietic cell transplant: high response rate but frequent GVHD BM Haverkos, D Abbott, M Hamadani, P Armand, ME Flowers, ... Blood, The Journal of the American Society of Hematology 130 (2), 221-228, 2017 | 274 | 2017 |
Axicabtagene ciloleucel in the non-trial setting: outcomes and correlates of response, resistance, and toxicity CA Jacobson, BD Hunter, R Redd, SJ Rodig, PH Chen, K Wright, ... Journal of Clinical Oncology 38 (27), 3095, 2020 | 260 | 2020 |
Phase I trial of maintenance sorafenib after allogeneic hematopoietic stem cell transplantation for fms-like tyrosine kinase 3 internal tandem duplication acute myeloid leukemia YB Chen, S Li, AA Lane, C Connolly, C Del Rio, B Valles, M Curtis, ... Biology of Blood and Marrow Transplantation 20 (12), 2042-2048, 2014 | 253 | 2014 |
Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States L Muffly, MC Pasquini, M Martens, R Brazauskas, X Zhu, K Adekola, ... Blood, The Journal of the American Society of Hematology 130 (9), 1156-1164, 2017 | 241 | 2017 |
An early-biomarker algorithm predicts lethal graft-versus-host disease and survival MJ Hartwell, U Özbek, E Holler, AS Renteria, H Major-Monfried, P Reddy, ... JCI insight 2 (3), 2017 | 237 | 2017 |
Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc … J Bolaños-Meade, R Reshef, R Fraser, M Fei, S Abhyankar, Z Al-Kadhimi, ... The Lancet Haematology 6 (3), e132-e143, 2019 | 230 | 2019 |
Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial M Jagasia, MA Perales, MA Schroeder, H Ali, NN Shah, YB Chen, S Fazal, ... Blood, The Journal of the American Society of Hematology 135 (20), 1739-1749, 2020 | 223 | 2020 |
Quality of life and mood of patients and family caregivers during hospitalization for hematopoietic stem cell transplantation AR El‐Jawahri, LN Traeger, K Kuzmuk, JR Eusebio, HB Vandusen, ... Cancer 121 (6), 951-959, 2015 | 223 | 2015 |
Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma MJ Frigault, J Dietrich, M Martinez-Lage, M Leick, BD Choi, Z DeFilipp, ... Blood, The Journal of the American Society of Hematology 134 (11), 860-866, 2019 | 214 | 2019 |
Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease J Koreth, HT Kim, KT Jones, PB Lange, CG Reynolds, MJ Chammas, ... Blood, The Journal of the American Society of Hematology 128 (1), 130-137, 2016 | 209 | 2016 |
Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity Z DeFilipp, JU Peled, S Li, J Mahabamunuge, Z Dagher, AE Slingerland, ... Blood advances 2 (7), 745-753, 2018 | 207 | 2018 |